Overview Money In Money Out People Positions Interview Endorsements
About To improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our CORE values of interaction/integration, innovation, translation, diversity and inclusion and leadership in the field. SITC AIMS to make cancer immunotherapy a standard of care and the word "CURE" a reality for cancer patients everywhere.
In care of TARA Withington
Donations are tax-deductible
Financial Snapshot FY ending 2024-12-31 Financial history 16 17 18 19 20 21 22 23 24
Revenue Expenses
Latest FY2024: $12.8M · Peak FY2022: $17.2M · Avg: $13.3M
Foreign activity (Schedule F) Total spent abroad $165K
Foreign employees 24
Foreign offices 0
Foreign partnership interest No
Foreign trust interest No
Region Activity Spent EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM — — EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, — — NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES — — NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES — —
Political & Grant Activity
SOCIETY FOR IMMUNOTHERAPY OF CANCER INC
Address 555 E Wells ST STE 1100
Milwaukee, WI, 53202-380
Governance Voting board members 13
Independent members 13
Conflict-of-interest policy Yes
Whistleblower policy Yes
Doc-retention policy Yes
Audit committee Yes
990 reviewed by board Yes
Financial detail (Schedule D) Board-designated % 100.0%
Endowment held by related org No
Public records
These open in a new tab. AllCiv doesn't host filings directly — these are the authoritative public-record sources.